SALL4 and cholangiocarcinoma: Clinically, SALL4 expression is enriched in combined or mixed HCC–CCA tumors, which display both hepatocytic and CC features reminiscent of bipotential progenitor-like cells such as hepatoblasts and LPCs (18).